Linked from

The 54 pages that link to Food and Drug Administration, each with the reason it gives.

• 2,4-DinitrophenolRelated: The agency acted against DNP’s medical use after reports of serious harm.

• AgomelatineRelated: Agomelatine is not approved for marketing in the United States.

• Elizabeth HolmesRelated: Regulatory scrutiny of Theranos raised questions about oversight of its blood-testing claims.

• MerbrominRelated: Its 1998 ruling ended over-the-counter marketing of merbromin in the United States.